Harvard Bioscience (HBIO) Enterprise Value (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Enterprise Value of -$7.1 million for Q1 2026, down 27.98% year-over-year from -$9.9 million in Q1 2025, and up 17.6% quarter-over-quarter from -$8.6 million in Q4 2025.
Harvard Bioscience (HBIO) Enterprise Value (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Enterprise Value for 17 consecutive years, with -$7.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 27.98% year-over-year to -$7.1 million; the TTM figure through Mar 2026 stood at -$7.1 million (down 27.98% YoY), while the FY2025 annual figure was -$8.6 million, down 109.69% from the prior year.
- Enterprise Value grew to -$7.1 million in Q1 2026 per HBIO's latest filing, from -$8.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$3.8 million in Q1 2023 and bottomed at -$8.6 million in Q4 2025.
- Historically, Enterprise Value has averaged -$5.3 million across 5 years, with a median of -$4.6 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 42.36% — and 2025, when it plunged 109.69%.
- Harvard Bioscience's Enterprise Value stood at -$4.5 million in 2022, then rose by 4.99% to -$4.3 million in 2023, then increased by 4.09% to -$4.1 million in 2024, then slumped by 109.69% to -$8.6 million in 2025, then advanced by 17.6% to -$7.1 million in 2026.
- Business Quant data shows HBIO's Enterprise Value at -$7.1 million in Q1 2026, -$8.6 million in Q4 2025, and -$6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | -6.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.50 Mn |
| Mar 31, 2026 | -7.10 Mn |
| Dec 31, 2025 | -8.61 Mn |
| Sep 30, 2025 | -6.82 Mn |
| Jun 30, 2025 | -7.44 Mn |
| Mar 31, 2025 | -5.55 Mn |
| Dec 31, 2024 | -4.11 Mn |
| Sep 30, 2024 | -4.57 Mn |
| Jun 30, 2024 | -4.05 Mn |
| Mar 31, 2024 | -4.26 Mn |
| Dec 31, 2023 | -4.28 Mn |
| Sep 30, 2023 | -5.34 Mn |
| Jun 30, 2023 | -4.32 Mn |
| Mar 31, 2023 | -3.79 Mn |
| Dec 31, 2022 | -4.51 Mn |
| Sep 30, 2022 | -5.14 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -5.43 Mn |
| Dec 31, 2021 | -7.82 Mn |
| Sep 30, 2021 | -5.55 Mn |